The Effect of Meal Composition on Blood Lipids

April 19, 2016 updated by: Meena Shah, Texas Christian University

The Effect of Meal Composition on Blood Lipid Concentrations

The purpose of this study is to see if a high-protein meal leads to a better postprandial (after a meal) blood lipid profile compared to a high-monounsaturated meal.

Study Overview

Detailed Description

The effect of a high-protein diet compared to a high-monounsaturated fat diet on fasting lipids is controversial (1,2), In addition, these studies did not examine the effect of a high-protein compared to a high-monounsaturated meal on postprandial lipid concentrations. Postprandial lipid responses are important to examine since they are associated with heart disease (3,4). In addition, most individuals in Western countries are in a postprandial state for majority of the day. The present study will compare the effect of a high-protein meal versus a high-monounsaturated fat meal on postprandial lipid responses.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Fort Worth, Texas, United States, 76129
        • Texas Christian University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women ages 18-65 years.

Exclusion Criteria:

  • Use of medications or supplements that affect lipid levels, body weight, or blood glucose,
  • following a weight loss diet,
  • being a vegan,
  • smoking,
  • heavy alcohol use,
  • pregnancy,
  • lactation,
  • severe depression,
  • eating disorders,
  • presence of liver, kidney, gastrointestinal, adrenal, or untreated thyroid disease,
  • diabetes,
  • lactose intolerance,
  • documented mal-absorption, or
  • bowel surgery that affects absorption.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-protein meal condition
The participants will be fed a high-protein meal
Active Comparator: High-monounsaturated fat meal condition
The participants will be fed a high-monounsaturated fat meal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Blood lipid concentrations.
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins

Secondary Outcome Measures

Outcome Measure
Time Frame
IL-6
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
TNF-α
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
C-reactive protein
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
GLP-1
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
Insulin
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
Glucagon
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
Glucose
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
Leptin
Time Frame: At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Meena Shah, Ph.D., Tzu Chi University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

August 14, 2015

First Submitted That Met QC Criteria

August 19, 2015

First Posted (Estimate)

August 20, 2015

Study Record Updates

Last Update Posted (Estimate)

April 21, 2016

Last Update Submitted That Met QC Criteria

April 19, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • TexasCU

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyslipidemia

Clinical Trials on High-Protein Condition

Subscribe